Familial HDL deficiency characterized by hypercatabolism of mature apoA-I but not proapoA-I

Arteriosclerosis, Thrombosis, and Vascular Biology
R BatalJ S Cohn

Abstract

We have previously described patients with familial high density lipoprotein (HDL) deficiency (FHD) having a marked reduction in the plasma concentration of HDL cholesterol and apolipoprotein (apo) A-I but lacking clinical manifestations of Tangier disease or evidence of other known causes of HDL deficiency. To determine whether FHD in these individuals was associated with impaired HDL production or increased HDL catabolism, we investigated the kinetics of plasma apoA-I and apoA-II in two related FHD patients (plasma apoA-I, 17 and 37 mg/dL) and four control subjects (apoA-I, 126+/-18 mg/dL, mean+/-SD) by using a primed constant infusion of deuterated leucine. Kinetic analysis of plasma apolipoprotein enrichment curves demonstrated that mature plasma apoA-I production rates (PRs) were similar in patients and control subjects (7.9 and 9.1 versus 10.5+/-1.7 mg x kg[-1] x d[-1]). Residence times (RTs) of mature apoA-I were, however, significantly less in FHD patients (0.79 and 1.66 days) compared with controls (5.32+/-1.05 days). Essentially normal levels of plasma proapoA-I (the precursor protein of apoA-I) in FHD patients were associated with normal plasma proapoA-I PRs (7.8 and 10.4 versus 10.9+/-2.6 mg x kg[-1] x d[-1]) and pr...Continue Reading

References

Jul 1, 1977·The Journal of Clinical Investigation·G AssmannT Forte
Oct 26, 1978·The New England Journal of Medicine·E J SchaeferH B Brewer
Jan 1, 1990·Journal of Cardiovascular Pharmacology·G Assmann, H Funke
Aug 8, 1991·The New England Journal of Medicine·M J StampferC H Hennekens
May 22, 1990·Biochimica Et Biophysica Acta·S ParthasarathyL G Fong
Jan 1, 1986·Methods in Enzymology·H B BrewerC Bishop
Dec 1, 1987·The Journal of Clinical Investigation·D BojanovskiH B Brewer
Apr 15, 1983·Biochemical and Biophysical Research Communications·S W LawH B Brewer
Jul 1, 1995·The Journal of Clinical Investigation·G A FrancisJ F Oram
Dec 1, 1993·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·J GenestE J Schaefer
Sep 1, 1997·Metabolism: Clinical and Experimental·L L BaussermanP N Herbert

❮ Previous
Next ❯

Citations

Mar 13, 2002·Atherosclerosis·Dmitri Sviridov, Paul Nestel
Apr 27, 2000·Atherosclerosis·P M Clifton, M Noakes
Apr 23, 2003·Molecular Genetics and Metabolism·Maxime DenisJacques Genest
May 9, 2006·Current Opinion in Lipidology·Larbi KrimbouJacques Genest
Dec 9, 2004·Atherosclerosis·Jean-François MaugerBenoît Lamarche
Jan 18, 2005·Journal of Lipid Research·Houssein Hajj HassanJacques Genest
Nov 28, 2002·Journal of Lipid Research·Bassam HaidarJacques Genest
Sep 18, 2002·Journal of Lipid Research·Jeffrey S CohnJean Davignon
Jan 1, 2004·The Journal of Biological Chemistry·Bassam HaidarJacques Genest
Aug 21, 2002·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·F PontB Vergès
Jun 25, 2005·Obesity Research·Esther M M OoiP Hugh R Barrett
Aug 22, 2006·European Journal of Clinical Investigation·E M M OoiP H R Barrett
Oct 13, 2006·The Journal of Biological Chemistry·Bassam HaidarYves L Marcel
Nov 17, 2006·Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis·Laura ObiciVittorio Bellotti
Feb 21, 2008·The Journal of Clinical Endocrinology and Metabolism·Hélène DuezGary F Lewis
Oct 24, 1998·Endocrinology and Metabolism Clinics of North America·J Davignon, J Genest

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.